Welcome to the November edition of GHP Magazine, providing you with a diverse range of news and exciting features.
In recent news, a late-stage life sciences investment firm that partners with companies to successfully bring novel medical therapies to market, Aisling Capital announced on the 2nd November the closing of its newest fund, with $280 million in committed capital. The capital raised will allow Aisling Capital to continue helping clinical stage ventures improve global health by more rapidly bringing breakthrough medical treatments to market.
Gracing the cover of this month’s issue, Texas A&M is one of the largest universities in the United States of America, with a current student body of more than 60,000 and a physical campus of more than 5,200 acres. We profiled the University in order to explore the secrets behind its success and what will help it go further in the future.
Speaking of success, founded in 2009, Cytosurge has invested considerable time and money to turn a laboratory idea into a commercially viable technology. We profiled the firm in order to find out what clients can expect when working with the company.
Lastly, we discover more about independent, internationally recognized health care accrediting body, Accreditation Commission for Health Care (ACHC). The organisation is focused on helping providers demonstrate compliance with applicable standards of practice and care. We learn more about accrediting body when we spoke to ACHC President and CEO, José Domingos to find out more about ACHC’s compliance solutions.
Here at GHP Magazine, we hope that you truly enjoy reading this edition and look forward to hearing from you soon.